FN2 Earnings Intelligence
Equifax Inc. financials
Equifax Inc. (EFX) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $224.7 | $285.2 | $216.8 | $169.9 | $180.8 | - | - |
| + Debt | $5,294.9 | $5,787.3 | $5,711.2 | $5,010.5 | $5,093.3 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $4,923.9 | $5,122.2 | $5,265.2 | $5,681.1 | $6,074.5 | $6,749.7 | $7,358.1 |
| % Growth | 19.3% | 4.0% | 2.8% | 7.9% | 6.9% | 11.1% | 9.0% |
| Gross Profit | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| EBITDA | $1,627.6 | $1,624.6 | $1,553.4 | $1,722.7 | $1,822.1 | - | - |
| % Margin | 33.1% | 31.7% | 29.5% | 30.3% | 30.0% | - | - |
| Net Income | $744.2 | $696.2 | $545.3 | $604.1 | $660.3 | - | - |
| % Margin | 15.1% | 13.6% | 10.4% | 10.6% | 10.9% | - | - |
| Diluted EPS | $6.02 | $5.65 | $4.40 | $4.84 | $5.32 | $8.57 | $10.17 |
| % Growth | 42.0% | -6.1% | -22.1% | 10.0% | 9.9% | 61.0% | 18.7% |
| Operating Cash Flow | $1,334.8 | $757.1 | $1,116.8 | $1,324.5 | $1,615.7 | - | - |
| CapEx | $469 | $624.5 | $601.3 | $511.5 | $481.4 | - | - |
| Free Cash Flow | $865.8 | $132.6 | $515.5 | $813 | $1,134.3 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $4,923.9 | $5,122.2 | $5,265.2 | $5,681.1 | $6,074.5 | $6,749.7 | $7,358.1 |
| Gross Profit | - | - | - | - | - | - | - |
| EBITDA | $1,627.6 | $1,624.6 | $1,553.4 | $1,722.7 | $1,822.1 | - | - |
| Net Income | $744.2 | $696.2 | $545.3 | $604.1 | $660.3 | - | - |
| Diluted EPS | $6.02 | $5.65 | $4.40 | $4.84 | $5.32 | $8.57 | $10.17 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $224.7 | $285.2 | $216.8 | $169.9 | $180.8 |
| Short-term Debt | $824.8 | $967.2 | $963.4 | $687.7 | $1,038 |
| Long-term Debt | $4,470.1 | $4,820.1 | $4,747.8 | $4,322.8 | $4,055.3 |
| Total Debt | $5,294.9 | $5,787.3 | $5,711.2 | $5,010.5 | $5,093.3 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1,334.8 | $757.1 | $1,116.8 | $1,324.5 | $1,615.7 |
| Capital Expenditure | $469 | $624.5 | $601.3 | $511.5 | $481.4 |
| Free Cash Flow | $865.8 | $132.6 | $515.5 | $813 | $1,134.3 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 19.3% | 4.0% | 2.8% | 7.9% | 6.9% |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 33.1% | 31.7% | 29.5% | 30.3% | 30.0% |
| Net Margin | 15.1% | 13.6% | 10.4% | 10.6% | 10.9% |
| FCF Margin | 17.6% | 2.6% | 9.8% | 14.3% | 18.7% |
| Diluted EPS Growth | 42.0% | -6.1% | -22.1% | 10.0% | 9.9% |